LabHealth
Lab studies find two drug targets in triple-negative breast cancer
The work remains preclinical, using human cells, organoids and laboratory models.
Written by AI2 sources2 min
Loading…
Diagnostics, prosthetics, vaccines, genomics: the medicine that adds years to a life.
The work remains preclinical, using human cells, organoids and laboratory models.
CREW was designed for women with cardiovascular disease in rural and remote communities.
A CDC and Emory study found the benefit across six high-burden countries using routine HIV program data.
A Phase 3 trial tested the drug in people with post-bariatric hypoglycemia.
College students reported less distress after five weeks of emotion-regulation training.
Princeton researchers found music activated brain networks for imagination and meaning.
L-BAIBA helps muscles adapt to exercise and improve their endurance.
About 5% of clear cell ovarian cancers showed high IL-17 activity.
Robotic CABG avoids cutting the breastbone, using small incisions between the ribs.
UCLA’s FLIMPSR reconstructs tissue images from scans with five times lower spatial resolution.
A study of 787 patients identifies tumor removal and treatment timing as survival factors.
ULTRA creates 3D virtual histology of glioma tissue in about 30 minutes.
A mouse study identifies TLR2 as a hub linking inflammation to heart repair.
In preclinical studies, a flexible implant read movement, sensation and organ signals.
Otp helps control stress, thyroid hormones and energy balance in adult mice.
Berkeley Lab scientists linked Huntington’s symptoms to widespread DNA breaks in mouse neurons.
MIT researchers found reusable prefrontal circuits in mice that store different kinds of memories.
Nearly half of patients on 15 mg reached 80% scalp coverage by week 24.